Lundby Group - Cardiac Proteomics
We apply data-driven strategies to uncover mechanisms involved in cardiac pathologies. Our research projects are anchored on deep quantitative proteomics investigations of heart samples that allow us to identify cellular and molecular alterations characterizing a cardiac disease state or cardiac perturbations. We are interested in understanding regulatory processes in the heart in general, but with a particular emphasis on cardiac molecular pathology. Our efforts are aimed at identifying drivers of cardiac pathologies and ultimately outline targets for cardiac disease intervention.
We believe the best strategy to develop better treatments for cardiac pathologies in the future is through improved understanding of the mechanisms driving the disease. Our research is focused on data-driven strategies to uncover cellular and molecular mechanisms involved in cardiac pathology.
We have established experimental approaches to quantify protein abundance changes as well as signaling pathway changes from small cardiac biospecimens. We pursue quantitative proteomics based experimental work analysing the molecular build-up of heart samples, and via multi-modal data integration we seek to identify molecular and cellular changes that characterize the disease state. In combination with functional studies in matched model organisms, these efforts enable data-driven strategies to identify cellular and molecular drivers of cardiac pathologies.
In essence, we pursue deep molecular phenotyping of patient heart samples anchored on proteomics-based approaches and integrate our experimental data with information from complimentary sources, such as genomics, single cell transcriptomics, spatial transcriptomics or pharmacovigilance. These efforts are focused at identifying cell sub-populations and proteins of key importance in molecular cardiac pathology.
Our research projects are usually anchored on a quantitative proteomics based investigation of a cardiac phenotype. In that sense projects often start with a mass spectrometry based proteomics investigation that is subsequently followed up by orthogonal experimental approached. We are a technology centered group and work on development of high-throughput quantitative approaches applied to basic and translational projects in cardiac research. The figure to the right illustrates our efforts in integrating information from proteomics based investigations of protein complexes in heart tissue with genomics data of a cardiac phenotype to pinpoint novel regulators of cardiac physiology.
Experimental and analytical strategies are developed as per project requirements. Common strategies applied by our group encompass Mass spectrometry based proteomics approaches:
As well as complementary experimental approaches such as:
Analytical approaches include:
One of our main efforts lie in development of high-throughput quantitative approaches for dynamic analysis of deep cardiac proteomes, which we apply to basic and translational projects in cardiac research. We use our technologies to quantify protein changes in cardiac disease states by analyzing human heart biopsies. To the left is an illustration from a study where we used quantitative proteomics to quantify all proteins in the cardiac pacemaker region, the sinus node. With the technology we can quantify abundances of more than 8,000 cardiac proteins. The figure illustrates the quantitative information of a small subset of these, specifically of the ion channels involved in the cardiac action potential generation. The protein abundances measured translates into an explanation for the electrophysiological phenotype.
Single cell RNA-seq
We strive to use the latest technologies in our projects and to pursue multi-modal investigations. By combining global proteomics data with information from single cell RNA sequencing, we can address the cardiac cell populations involved in the responses investigated. The figure is an example of single cell transcriptomics data we generated from the cardiac sinus node.
Phospho-proteomics and Post-Translational Modifications
Phosphorylation mediated signaling is a primary mechanism for dynamical signaling responses in the heart. We are developing and applying quantitative phosphoproteomics approaches to quantify phosphorylation mediated signaling directly in cardiac tissue samples. We have previously reported the beta-adrenergic signaling response in heart tissue, as illustrated in the figure on the left. Recently we also discovered how different wiring in the phosphorylation signaling networks are involved in the impact of exercise on the cardiac disorder ARVC
Optical voltage mapping in zebrafish
We use multiple experimental strategies to functionally follow up on the findings we make. One strategy we apply is optogenetics. We use zebrafish as a model organism to study human cardiac diseases and generate knockdowns using CRISPR/Cas9 technology. Hearts of genetically modified animals are phenotyped and we measure the cardiac electrical activity and calcium transients using voltage sensitive dyes. These approaches facilitate interpretation of the molecular mechanism behind cardiac diseases at the organ level.
We are always interested in hearing from qualified research candidates interested in joining our group. Please send enquiry directly to Professor Lundby including a CV and transcript records.
We continuously have experimental as well as informatics based projects available for Masters Students. Email Professor Lundby with enquiries.
|Christian Frøkjær-Jensen||Affiliate Associate Professor|
|Estefania Torres Vega||Postdoc||+4535337369|
|Finn Benned Hansen||Guest Researcher|
|Jonathan Samuel Achter||PhD Fellow|
|Mikkel Skjoldan Svenningsen||Postdoc||+4542674334|
|Robert William Mills||Assistant Professor|
|Sergio d'Anna||Research Assistant|
|Signe Lykke Nielsen||Biomedical Laboratory Scientist||+4535331037|